Studies of the antioxidant α-lipoic acid (ALA) found no significant improvement in cardiovascular autonomic dysfunction in T2DM patients [272,273] despite one study that found ALA treatment significantly reduced serum levels of the pro-inflammatory proteins, CRP, IL-6, IL-8, and TNF-α [274]. This evidence concerns the gene CRP and type 2 diabetes mellitus.